PhRMA to accept inflation caps

PhRMA is prepared to accept a cap on drug price increases, biopharma executives involved in drafting the trade association’s response to the Trump administration’s drug pricing blueprint told BioCentury.

The PhRMA board is considering a proposal that would commit members to limit price increases for drugs purchased by Medicare to a measure of consumer inflation. ...